Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q3 2025 Earnings Call Transcript
Operator: Welcome to the Crinetics Pharmaceuticals Third Quarter 2025 Financial Results Conference Call. I would now like to turn the call over to Gayathri Diwakar, Head of Investor Relations.





